Get the Stockscreener App
19.26
0.93%
-0.18
After Hours:
19.26
Jade Biosciences Inc stock is traded at $19.26, with a volume of 289.45K.
It is down -0.93% in the last 24 hours and up +38.36% over the past month.
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
See More
Previous Close:
$19.44
Open:
$19.32
24h Volume:
289.45K
Relative Volume:
0.72
Market Cap:
$949.83M
Revenue:
-
Net Income/Loss:
$-91.76M
P/E Ratio:
-3.5313
EPS:
-5.4541
Net Cash Flow:
$-94.89M
1W Performance:
+14.92%
1M Performance:
+38.36%
6M Performance:
+94.55%
1Y Performance:
+0.00%
1-Day Range:
$19.06
$20.05
1-Week Range:
$16.33
$20.05
52-Week Range:
$6.565
$20.05
Jade Biosciences Inc Stock (JBIO) Company Profile
Name
Jade Biosciences Inc
Sector
Industry
Phone
(781) 312-3013
Address
221 CRESCENT ST., WALTHAM
Compare JBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
19.26 | 958.71M | 0 | -91.76M | -94.89M | -5.4541 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-26 | Initiated | H.C. Wainwright | Buy |
| Oct-09-25 | Initiated | BTIG Research | Buy |
| Jul-14-25 | Initiated | Jefferies | Buy |
| Jun-16-25 | Upgrade | Guggenheim | Neutral → Buy |
| May-07-25 | Initiated | Wedbush | Outperform |
| May-05-25 | Initiated | Stifel | Buy |
| May-02-25 | Initiated | TD Cowen | Buy |
| Jun-18-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-18-24 | Downgrade | TD Cowen | Buy → Hold |
| Jun-18-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-17-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-17-24 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-25-24 | Resumed | Jefferies | Buy |
| Dec-08-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-01-23 | Initiated | Guggenheim | Buy |
| Dec-06-22 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-19-22 | Resumed | Wedbush | Outperform |
| Aug-16-22 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-11-22 | Initiated | BTIG Research | Buy |
| Jul-26-21 | Initiated | Cowen | Outperform |
| Jul-26-21 | Initiated | Evercore ISI | Outperform |
| Jul-26-21 | Initiated | Jefferies | Buy |
| Jul-26-21 | Initiated | Wedbush | Outperform |
View All
Jade Biosciences Inc Stock (JBIO) Latest News
Jade Biosciences (JBIO) price target increased by 10.24% to 28.82 - MSN
Jade Biosciences (JBIO) price target increased by 16.48% to 26.14 - MSN
Volume Report: Is Jade Biosciences Inc a stock for growth or value investorsInsider Buying & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update - ADVFN
Aug Drivers: Is Jade Biosciences Inc a stock for growth or value investors2026 PreEarnings & Weekly Watchlist of Top Performers - baoquankhu1.vn
867,284 Shares in Jade Biosciences, Inc. $JBIO Bought by Aberdeen Group plc - Defense World
Jade Biosciences Adopts 2026 Employment Inducement Stock Plan - TipRanks
Jade Biosciences adopts 2026 Employment Inducement Stock Incentive Plan - TradingView
Jade Biosciences, Inc. (NASDAQ:JBIO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Breakout Zone: Will Jade Biosciences Inc benefit from current market trends2026 Buyback Activity & Precise Trade Entry Recommendations - baoquankhu1.vn
Companies Like Jade Biosciences (NASDAQ:JBIO) Are In A Position To Invest In Growth - Yahoo Finance
HC Wainwright Issues Pessimistic Outlook for JBIO Earnings - Defense World
HC Wainwright Lowers Earnings Estimates for Jade Biosciences - MarketBeat
Smart Money: What is the PEG ratio of Jade Biosciences Inc2026 Snapshot & Verified Swing Trading Watchlist - baoquankhu1.vn
JBIO Analyst Rating Update: HC Wainwright Raises Price Target to $35 | JBIO Stock News - GuruFocus
H.C. Wainwright raises Jade Biosciences stock price target to $35 By Investing.com - Investing.com Canada
Jade Biosciences (NASDAQ:JBIO) Price Target Raised to $35.00 at HC Wainwright - MarketBeat
H.C. Wainwright Maintains Jade Biosciences(JBIO.US) With Buy Rating, Raises Target Price to $35 - Moomoo
Jade Biosciences, Inc.(NasdaqCM: JBIO) added to S&P Biotechnology Select Industry Index - MarketScreener
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - MSN
BTIG raises Jade Biosciences stock price target on pricing outlook By Investing.com - ca.investing.com
Portfolio Recap: Is Jade Biosciences Inc forming a bullish divergenceWeekly Trading Summary & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Jade Biosciences (NASDAQ:JBIO) Shares Gap Up After Analyst Upgrade - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Price Target Raised to $39.00 at BTIG Research - MarketBeat
JBIO SEC FilingsJade Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Jade Biosciences (NASDAQ:JBIO) Stock Price Expected to Rise, Guggenheim Analyst Says - Defense World
Jade Biosciences (NASDAQ:JBIO) Cut to Strong Sell at Zacks Research - Defense World
Zacks Research Downgrades Jade Biosciences (NASDAQ:JBIO) to Strong Sell - MarketBeat
Guggenheim Forecasts Strong Price Appreciation for Jade Biosciences (NASDAQ:JBIO) Stock - MarketBeat
Guggenheim raises Jade Biosciences stock price target on pipeline progress By Investing.com - Investing.com Canada
William Blair Upgrades Jade Biosciences (NASDAQ:JBIO) to Strong-Buy - Defense World
Jade Biosciences (NASDAQ:JBIO) Sees Large Volume Increase Following Analyst Upgrade - Defense World
Jade Biosciences (NASDAQ:JBIO) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Jade Biosciences (NASDAQ:JBIO) Raised to "Strong-Buy" at William Blair - MarketBeat
TD Cowen reiterates Jade Biosciences stock rating on APRIL data By Investing.com - Investing.com Canada
William Blair initiates Jade Biosciences stock coverage with Outperform rating - Investing.com UK
Trading Recap: Is Jade Biosciences Inc a speculative investment2026 Breakouts & Accurate Buy Signal Alerts - baoquankhu1.vn
Wedbush Reaffirms Outperform Rating for Jade Biosciences (NASDAQ:JBIO) - MarketBeat
William Blair initiates Jade Biosciences stock coverage with Outperform rating By Investing.com - Investing.com India
Signal Recap: Is Jade Biosciences Inc a speculative investment2026 Historical Comparison & Weekly Stock Performance Updates - baoquankhu1.vn
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - marketbeat.com
Jade Biosciences (NASDAQ:JBIO) Raised to “Strong-Buy” at Lifesci Capital - Defense World
Jade Biosciences (NASDAQ:JBIO) Upgraded by Lifesci Capital to "Strong-Buy" Rating - MarketBeat
Jade Biosciences Inc Stock (JBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):